Ashwagandha: Adaptogen Science, Cortisol Data, and Clinical Reality
An evidence-based review of ashwagandha (Withania somnifera) covering cortisol reduction data, stress and anxiety RCTs, testosterone claims, KSM-66 vs Sensoril extracts, and safety considerations.
Lead Science Writer · Peer-Reviewed Sources
Ashwagandha (Withania somnifera) is an adaptogenic herb with over 3,000 years of use in Ayurvedic medicine. In the past decade, it has become one of the fastest-growing supplements in Western markets, driven by clinical trials showing measurable effects on cortisol, anxiety, and stress resilience.
But how strong is the evidence really? And do the popular branded extracts live up to their marketing?
Mechanism of Action
Ashwagandha’s active compounds are withanolides — steroidal lactones that modulate multiple pathways:
- HPA axis modulation: Reduces cortisol output by attenuating hypothalamic-pituitary-adrenal axis hyperactivity
- GABAergic activity: Withanolides act as positive allosteric modulators at GABA-A receptors, explaining anxiolytic effects
- Anti-inflammatory: Inhibits NF-κB signaling and reduces inflammatory cytokines (TNF-α, IL-6)
- Thyroid support: May increase T3 and T4 levels in subclinical hypothyroid patients
Stress and Cortisol: The Evidence
This is ashwagandha’s strongest evidence area.
A 2019 systematic review in Medicine (5 RCTs, n=400+) found ashwagandha supplementation significantly reduced serum cortisol compared to placebo, with an average reduction of 11-32% depending on the study and extract used.
Key individual trials:
- Salve et al. (2019): 60 adults, 600mg KSM-66 for 8 weeks. Results: 27% reduction in morning cortisol vs. placebo. Significant improvements in perceived stress scale and sleep quality.
- Chandrasekhar et al. (2012): 64 adults with chronic stress, 600mg root extract for 60 days. Results: 28% cortisol reduction, significant improvement in all stress-assessment scales.
- Lopresti et al. (2019): 60 adults, 240mg Shoden extract for 60 days. Results: 23% cortisol reduction even at this lower dose.
Anxiety: Clinical Data
A 2014 systematic review in the Journal of Alternative and Complementary Medicine (5 RCTs) concluded ashwagandha demonstrated significant anxiety reduction compared to placebo across all reviewed trials.
The effect size is moderate but consistent — comparable to some prescription anxiolytics in mild-to-moderate anxiety, though direct comparison trials are lacking.
Testosterone and Performance Claims
This area gets more hype than the data supports:
- Testosterone: A 2019 meta-analysis found ashwagandha increased testosterone by an average of 14.7% in men — but most subjects were infertile, stressed, or untrained. The effect in healthy young men with normal testosterone is likely much smaller.
- Strength and muscle: A 2015 JISSN study found 600mg KSM-66 with resistance training increased bench press 1RM by 20kg vs 10kg in placebo. However, this was a small study (n=57) and the magnitude seems unusually large.
Honest assessment: Ashwagandha likely provides a modest testosterone boost (5-10%) in stressed or deficient individuals, primarily by reducing cortisol. It is not a testosterone replacement.
KSM-66 vs Sensoril vs Generic
- KSM-66: Full-spectrum root extract, standardized to 5% withanolides. Most clinical research uses this extract. Standard dose: 600mg/day.
- Sensoril: Root + leaf extract, standardized to 10% withanolides. Higher withanolide concentration per mg. Standard dose: 125-250mg/day.
- Generic: Variable quality, unstandardized withanolide content. Less predictable effects.
Both branded extracts have clinical evidence. KSM-66 has more published trials. Sensoril may be more potent per mg but has fewer studies.
Dosing
| Extract | Standard Dose | Timing |
|---|---|---|
| KSM-66 | 300-600mg/day | Morning or evening |
| Sensoril | 125-250mg/day | Evening (more sedating) |
| Generic (5% withanolides) | 300-600mg/day | Split or single dose |
Effects typically appear within 2-4 weeks. Cortisol reduction is often measurable within 8 weeks.
Safety Concerns
Ashwagandha is generally well-tolerated, but several concerns deserve attention:
- Liver toxicity: Multiple case reports of ashwagandha-associated liver injury have been reported since 2020. The WHO issued an alert in 2023. Most cases resolved upon discontinuation, but this warrants attention. Consider cycling (8 weeks on, 2-4 weeks off).
- Thyroid: May increase thyroid hormone levels. Those with hyperthyroidism or on thyroid medication should avoid or monitor closely.
- Pregnancy: Traditionally contraindicated. No safety data in pregnancy.
- Autoimmune conditions: Immune-stimulating properties may theoretically worsen autoimmune conditions.
- Drug interactions: May potentiate sedatives, thyroid medications, and immunosuppressants.
The Bottom Line
Ashwagandha has legitimate evidence for stress reduction and cortisol modulation. The anxiety data is consistent across multiple trials. Testosterone and performance claims are overstated for healthy individuals. Use a standardized extract (KSM-66 or Sensoril), expect effects in 2-4 weeks, consider cycling for safety, and be aware of the emerging liver toxicity reports.